Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,963 public trials 2,020 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Recruiting

Newly-diagnosed Pediatric T-cell ALL Protocol

NCT06855810

Conditions
Acute Lymphoblastic Leukemia, Childhood Leukemia, Acute Lymphoblastic, Hematologic Diseases, +12 more
Locations
  • Anhui Medical University Second Affiliated Hospital Hefei, Anhui, China
  • Anhui Provincial Children's Hospital Hefei, Anhui, China
  • Chongqing Medical University Affiliated Children's Hospital Chongqing, Chongqing Municipality, China
  • Fujian Medical University Union Hospital Fuzhou, Fujian, China
View all 27 locations
View Trial Details
Recruiting

Newly-diagnosed Low Risk Pediatric B-cell ALL Protocol

NCT06882057

Conditions
Acute Lymphoblastic Leukemia ALL, B Cell Acute Lymphoblastic Leukemia (B-ALL), Burkitt Lymphoma, +21 more
Locations
  • Anhui Medical University Second Affiliated Hospital Hefei, Anhui, China
  • Anhui Provincial Children's Hospital Hefei, Anhui, China
  • Chongqing Medical University Affiliated Children's Hospital Chongqing, Chongqing Municipality, China
  • Fujian Medical University Union Hospital Fuzhou, Fujian, China
View all 27 locations
View Trial Details
Recruiting

Study Evaluating UCART20x22 in B-Cell Non-Hodgkin Lymphoma

NCT05607420

Conditions
B-cell Non-Hodgkin Lymphoma (B-NHL), Disease Attributes, Hemic and Lymphatic Diseases, +12 more
Locations
  • The University of Chicago Medical Center (UCMC) Chicago, Illinois, United States
  • Harvard Medical School - Massachusetts General Hospital Boston, Massachusetts, United States
  • Rutgers Cancer Institute of New Jersey (CINJ) - New Brunswick New Brunswick, New Jersey, United States
  • Sarah Cannon - St. David South Austin Medical Center Austin, Texas, United States
View Trial Details
Recruiting

Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma

NCT05798897

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Hodgkin Disease, +18 more
Locations
  • City of Hope Duarte, California, United States
  • University of Colorado Aurora, Colorado, United States
  • Colorado Blood Cancer Institute (Sarah Cannon) Denver, Colorado, United States
  • University of Kansas Medical Center Kansas City, Kansas, United States
View Trial Details

Related conditions